Pharmacokinetic Optimization of CCG-203971: Novel Inhibitors of the Rho/MRTF/SRF Transcriptional Pathway as Potential Antifibrotic Therapeutics for Systemic Scleroderma

Por Hutchings, Kim M., Lisabeth, Erika M., Rajeswaran, Walajapet, Wilson, Michael W., Sorenson, Roderick J., Campbell, Phillip L., Ruth, Jeffrey H., Amin, Asif, Tsou, Pei-Suen, Leipprandt, Jeffrey R., Olson, Samuel R., Wen, Bo, Zhao, Ting, Sun, Duxin, Khanna, Dinesh, Fox, David A., Neubig, Richard R., Larsen, Scott D.
Publicado no Bioorg Med Chem Lett (2017)